Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

Part of paid clinical trials in Evanston, Illinois.

Sponsor
Boston Scientific Corporation
Study ID
NCT06894498
Status
Recruiting
Apply to this trial

Conditions

  • Obesity and Obesity-related Medical Conditions
  • Weight Loss

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No Intervention: Observational Cohort — OTHER
    No Intervention, Observational Cohort

Study Details

The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment.

Key Dates

Start date
Mar 31, 2026
Status verified
May 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

Proportion of subjects that maintain clinically significant weightloss at five-year visit [ Time Frame: TBWL assessed at five-years post ESG ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Endeavor Health Evanston HospitalEvanstonIllinois60201
Selma Zukancic
[email protected]
847-570-3802
Michael Ujiki, MD (PRINCIPAL_INVESTIGATOR)
The University of Texas Health Science Center at HoustonBellaireTexas77401
Clinical Research Manager
[email protected]
713-486-1350
Erik Wilson, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Evanston, IL

By research site
Endeavor Health Evanston Hospital· Evanston, ILThe University of Texas Health Science Center at Houston· Bellaire, TX

Related Studies